Norfolk, VANCT07224893Now EnrollingIRB Ready

Pregestational Diabetes Clinical Trial in Norfolk, VA

Access cutting-edge pregestational diabetes treatment through this phase 4 clinical trial at a research site in Norfolk. Study-provided care at no cost to qualified participants.

Sponsored by Eastern Virginia Medical School

Quick Self-Assessment

See if you qualify for this Norfolk location

Preparing your pre-screening questions…

Expert Care in Norfolk

Access pregestational diabetes specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pregestational diabetes treatment provided free

Apply for This Norfolk Location

Check if you qualify for this pregestational diabetes clinical trial in Norfolk, VA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Norfolk

    Convenient for VA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Norfolk site if eligible
  4. 4Begin participation

About This Pregestational Diabetes Study in Norfolk

The purpose of this study is to determine if taking insulin glargine twice a day instead of once a day will better manage pregestational diabetes in pregnant patients. Participants in this study will be randomly assigned to one of two groups: a group that takes insulin glargine once a day, and a group that takes it twice. Continuous glucose monitoring will be used to track blood sugar levels. The main question the study aims to answer is: Will using insulin glargine twice a day instead of once lead to a better glucose time in range?

Sponsor: Eastern Virginia Medical School

Who Can Participate

Inclusion Criteria

Patients older than 18 years of age;
The patient is fluent in English, physically and mentally able to understand the informed consent, and is willing to participate in this study;
Type II diabetes mellitus requiring insulin;
The patient is between 24 weeks 0 days and 28 weeks 0 days of gestation at the time of enrollment. Gestational age will be determined by last menstrual period, confirmed with a first trimester ultrasound, per the recommended guidelines by the American College of Obstetricians and Gynecologists.
Currently using or willing to use a clinically indicated continuous glucose monitor for glycemic management

Exclusion Criteria

Known allergy or reaction to insulin glargine, or concurrent medical condition where the use of insulin glargine is contraindicated;
Contraindication to CGM use, patient declines CGM use, or CGM not covered by patient's insurance;
Known or suspected fetal anomaly or aneuploidy;
Ongoing prenatal care outside EVMS or planned delivery outside Sentara Norfolk General Hospital.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Norfolk?

Yes, this clinical trial (NCT07224893) has an active research site in Norfolk, VA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pregestational Diabetes Treatment Options in Norfolk, VA

If you're searching for pregestational diabetes treatment options in Norfolk, VA, this clinical trial (NCT07224893) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Norfolk research site is actively enrolling participants for this phase 4 clinical trial. You'll receive care from experienced pregestational diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pregestational diabetes clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Norfolk, VA

See all essential tremor clinical trials recruiting in Norfolk — not just this study.

Browse Essential Tremor Trials in Norfolk →

Ready to Join in Norfolk?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Norfolk, VA